|
Market Closed -
Nasdaq
16:00:00 2026-09-04 EDT
|
5-day change | 1st Jan Change | ||
| 26.76 USD | -1.47% |
|
-2.94% | +24.58% |
| 08-12 | Wedbush Adjusts Price Target on Immunome to $35 From $31, Keeps Outperform Rating | MT |
| 08-11 | Immunome, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| Market Cap | 3.04B 2.62B 2.46B 2.25B 4.21B 287B 4.22B 29.08B 11.28B 147B 11.41B 11.16B 474B | P/E 2026 * |
-11.2x | P/E 2027 * | -10.2x |
|---|---|---|---|---|---|
| Enterprise Value | 2.8B 2.41B 2.26B 2.07B 3.87B 264B 3.88B 26.75B 10.38B 135B 10.5B 10.27B 436B | EV / Sales 2026 * |
8,387x | EV / Sales 2027 * | 52.3x |
| Free-Float |
93.42% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| IMNM | Delayed | |
CBOE
| IMNM | Real-time |
Last Transcript : Immunome, Inc.
| 1 day | -1.47% | ||
| 1 week | -2.94% | ||
| Current month | -2.37% | ||
| 1 month | +6.78% | ||
| 3 months | +35.98% | ||
| 6 months | +18.83% | ||
| Current year | +24.58% |
| 1 week | 26.64 |  | 28.48 |
| 1 month | 24.49 | | 30.06 |
| Current year | 17.83 | | 30.06 |
| 1 year | 8.66 | | 30.06 |
| 3 years | 5.15 | | 30.96 |
| 5 years | 2.09 | | 30.96 |
| 10 years | 2.09 | | 63.78 |
| Manager | Title | Age | Since |
|---|---|---|---|
Clay Siegall
CEO | Chief Executive Officer | 65 | 2023-10-01 |
Max Rosett
DFI | Director of Finance/CFO | 36 | 2024-01-01 |
Philip Tsai
CTO | Chief Tech/Sci/R&D Officer | 58 | 2024-06-26 |
| Director | Title | Age | Since |
|---|---|---|---|
Philip Wagenheim
BRD | Director/Board Member | 55 | 2016-12-31 |
Clay Siegall
CHM | Chairman | 65 | 2023-10-01 |
Isaac Barchas
BRD | Director/Board Member | 58 | 2023-10-01 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/12/26 | Sell | Director | -11,048 | 0.0098% | ||
| 8/6/26 | Other | Director | 0 | 0% | ||
| 8/4/26 | Exercice | Executive/Senior Manager | 271,848 | 0.2400% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.47% | -2.94% | +173.06% | +309.17% | 3.04B | |
| -1.79% | -2.27% | +50.90% | +89.03% | 67.98B | |
| -2.06% | -0.18% | +41.53% | +88.17% | 64.94B | |
| -0.31% | +6.54% | -11.39% | +457.82% | 27.58B | |
| -3.00% | -2.90% | +39.40% | +9.41% | 25.74B | |
| +0.86% | +1.65% | +0.25% | -14.78% | 26.06B | |
| -1.46% | +0.42% | +24.07% | -18.70% | 20.09B | |
| -2.96% | -15.21% | +210.71% | +370.84% | 17.16B | |
| -1.49% | -4.88% | -0.41% | +530.26% | 14.92B | |
| -0.20% | +8.37% | +57.87% | +159.50% | 14.62B | |
| Average | -1.39% | -0.06% | +58.60% | +198.07% | 28.21B | |
| Weighted average by Cap. | -1.52% | +0.14% | +43.70% | +146.85% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 333K 287K 270K 247K 461K 31.47M 462K 3.19M 1.24M 16.15M 1.25M 1.22M 52.02M | 55.56M 47.81M 44.98M 41.09M 76.87M 5.25B 77.08M 532M 206M 2.69B 209M 204M 8.67B |
| Net income | -273M -235M -221M -202M -378M -25.77B -379M -2.61B -1.01B -13.22B -1.02B -1B -42.59B | -316M -272M -256M -234M -438M -29.88B -439M -3.03B -1.17B -15.33B -1.19B -1.16B -49.39B |
| Net Debt | -244M -210M -197M -180M -337M -23B -338M -2.33B -904M -11.8B -915M -895M -38.02B | -132M -113M -107M -97.31M -182M -12.42B -183M -1.26B -488M -6.37B -494M -483M -20.53B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-04 | US$26.76 | -1.47% | 562,401 |
| 26-09-03 | US$27.16 | -0.62% | 796,416 |
| 26-09-02 | US$27.33 | +0.98% | 811,103 |
| 26-09-01 | US$27.07 | -1.26% | 700,168 |
| 26-08-31 | US$27.41 | -0.58% | 1,050,739 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- IMNM Stock
Select your edition
All financial news and data tailored to specific country editions
